BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 26298635)

  • 21. Immunohistochemical detection of BRAF V600E mutant protein using the VE1 antibody in colorectal carcinoma is highly concordant with molecular testing but requires rigorous antibody optimization.
    Kuan SF; Navina S; Cressman KL; Pai RK
    Hum Pathol; 2014 Mar; 45(3):464-72. PubMed ID: 24529329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas.
    Samowitz WS; Powers MD; Spirio LN; Nollet F; van Roy F; Slattery ML
    Cancer Res; 1999 Apr; 59(7):1442-4. PubMed ID: 10197610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.
    Zheng HC; Xia P; Xu XY; Takahashi H; Takano Y
    Hum Pathol; 2011 Mar; 42(3):424-33. PubMed ID: 21193223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors.
    Bonnet S; Gaujoux S; Launay P; Baudry C; Chokri I; Ragazzon B; Libé R; René-Corail F; Audebourg A; Vacher-Lavenu MC; Groussin L; Bertagna X; Dousset B; Bertherat J; Tissier F
    J Clin Endocrinol Metab; 2011 Feb; 96(2):E419-26. PubMed ID: 21084400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
    Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
    Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using a combination of cytochrome P450 1B1 and beta-catenin for early diagnosis and prevention of colorectal cancer.
    Chang H; Su JM; Huang CC; Liu LC; Tsai CH; Chou MC; Lin P
    Cancer Detect Prev; 2005; 29(6):562-9. PubMed ID: 16289386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macroscopic morphologic subtypes of laterally spreading colorectal tumors showing distinct molecular alterations.
    Sugimoto T; Ohta M; Ikenoue T; Yamada A; Tada M; Fujishiro M; Ogura K; Yamaji Y; Okamoto M; Kanai F; Kawabe T; Omata M
    Int J Cancer; 2010 Oct; 127(7):1562-9. PubMed ID: 20091866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear translocation of beta-catenin in colorectal cancer.
    Kobayashi M; Honma T; Matsuda Y; Suzuki Y; Narisawa R; Ajioka Y; Asakura H
    Br J Cancer; 2000 May; 82(10):1689-93. PubMed ID: 10817505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Wif-1 methylation and β-catenin expression in colorectal serrated lesions].
    Fang Y; Wang L; Zhang Y; Ge C; Xu C
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):15-9. PubMed ID: 24713243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signal transducers and activators of transcription 3 activation is involved in nuclear accumulation of beta-catenin in colorectal cancer.
    Kawada M; Seno H; Uenoyama Y; Sawabu T; Kanda N; Fukui H; Shimahara Y; Chiba T
    Cancer Res; 2006 Mar; 66(6):2913-7. PubMed ID: 16540637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do serrated neoplasms of the small intestine represent a distinct entity? Pathological findings and molecular alterations in a series of 13 cases.
    Rosty C; Campbell C; Clendenning M; Bettington M; Buchanan DD; Brown IS
    Histopathology; 2015 Feb; 66(3):333-42. PubMed ID: 24894811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatic mutations of the APC, KRAS, and TP53 genes in nonpolypoid colorectal adenomas.
    van Wyk R; Slezak P; Hayes VM; Buys CH; Kotze MJ; de Jong G; Rubio C; Dolk A; Jaramillo E; Koizumi K; Grobbelaar JJ
    Genes Chromosomes Cancer; 2000 Feb; 27(2):202-8. PubMed ID: 10612810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors.
    Takeda K; Kinoshita I; Shimizu Y; Ohba Y; Itoh T; Matsuno Y; Shichinohe T; Dosaka-Akita H
    BMC Cancer; 2008 Nov; 8():328. PubMed ID: 18992165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular changes in the Ki-ras and APC genes in colorectal adenomas and carcinomas arising in the same patient.
    Zauber NP; Sabbath-Solitare M; Marotta SP; Zauber AG; Bishop DT
    J Pathol; 2001 Mar; 193(3):303-9. PubMed ID: 11241408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
    Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
    Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of composite intestinal adenoma-microcarcinoid in 158 surgically resected polyps and its association with squamous morule.
    Fu Z; Saade R; Koo BH; Jennings TA; Lee H
    Ann Diagn Pathol; 2019 Oct; 42():69-74. PubMed ID: 31326865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRAF mutation is associated with the unique morphology of traditional serrated adenoma of the colorectum.
    Shi Y; Li J; Wu SY; Qin L; Jiao YF
    Int J Surg Pathol; 2013 Oct; 21(5):442-8. PubMed ID: 23960272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morules in cribriform-morular variant of papillary thyroid carcinoma: Immunohistochemical characteristics and distinction from squamous metaplasia.
    Hirokawa M; Kuma S; Miyauchi A; Qian ZR; Nakasono M; Sano T; Kakudo K
    APMIS; 2004; 112(4-5):275-82. PubMed ID: 15233643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flat adenoma-carcinoma sequence with high-malignancy potential as demonstrated by CD10 and beta-catenin expression: a different pathway from the polypoid adenoma-carcinoma sequence.
    Koga Y; Yao T; Hirahashi M; Kumashiro Y; Ohji Y; Yamada T; Tanaka M; Tsuneyoshi M
    Histopathology; 2008 Apr; 52(5):569-77. PubMed ID: 18370954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer.
    Jass JR; Baker K; Zlobec I; Higuchi T; Barker M; Buchanan D; Young J
    Histopathology; 2006 Aug; 49(2):121-31. PubMed ID: 16879389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.